Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Incidence of cervical intraepithelial neoplasia grade 2 or worse in colposcopy-negative/human papillomavirus-positive women with low-grade cytological abnormalities.

Kelly RS, Walker P, Kitchener H, Moss SM.

BJOG. 2012 Jan;119(1):20-5. doi: 10.1111/j.1471-0528.2011.02970.x. Epub 2011 May 31.

2.

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.

Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.

3.

HPV testing in primary screening of older women.

Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P.

Br J Cancer. 1999 Oct;81(3):554-8.

4.

High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.

Denise Zielinski G, Snijders PJ, Rozendaal L, Voorhorst FJ, Runsink AP, de Schipper FA, Meijer CJ.

J Pathol. 2001 Oct;195(3):300-6.

PMID:
11673826
5.

HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study.

Kelly RS, Patnick J, Kitchener HC, Moss SM; NHSCSP HPV Special Interest Group.

Br J Cancer. 2011 Sep 27;105(7):983-8. doi: 10.1038/bjc.2011.326. Epub 2011 Sep 6.

6.
7.

Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less.

Pretorius RG, Peterson P, Azizi F, Burchette RJ.

Am J Obstet Gynecol. 2006 Nov;195(5):1260-5.

PMID:
17074547
9.

The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial.

Cotton S, Sharp L, Little J, Cruickshank M, Seth R, Smart L, Duncan I, Harrild K, Neal K, Waugh N; Trial Of Management of Borderline and Other Low-grade Abnormal Smears Group.

BJOG. 2010 May;117(6):645-59. doi: 10.1111/j.1471-0528.2010.02519.x.

10.

HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia.

Kitchener HC, Walker PG, Nelson L, Hadwin R, Patnick J, Anthony GB, Sargent A, Wood J, Moore C, Cruickshank ME.

BJOG. 2008 Jul;115(8):1001-7. doi: 10.1111/j.1471-0528.2008.01748.x. Epub 2008 May 22.

11.

Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,.

Bratti MC, Rodríguez AC, Schiffman M, Hildesheim A, Morales J, Alfaro M, Guillén D, Hutchinson M, Sherman ME, Eklund C, Schussler J, Buckland J, Morera LA, Cárdenas F, Barrantes M, Pérez E, Cox TJ, Burk RD, Herrero R.

Rev Panam Salud Publica. 2004 Feb;15(2):75-89.

PMID:
15030652
12.

Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.

Kreimer AR, Guido RS, Solomon D, Schiffman M, Wacholder S, Jeronimo J, Wheeler CM, Castle PE.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):908-14.

13.

Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

BJOG. 2006 Nov;113(11):1303-7. Epub 2006 Sep 15.

14.

Economic analysis of human papillomavirus triage, repeat cytology, and immediate colposcopy in management of women with minor cytological abnormalities in Sweden.

Ostensson E, Fröberg M, Hjerpe A, Zethraeus N, Andersson S.

Acta Obstet Gynecol Scand. 2010 Oct;89(10):1316-25. doi: 10.3109/00016349.2010.512066. Erratum in: Acta Obstet Gynecol Scand. 2010 Nov;89(11):1497.

PMID:
20846064
15.

Smoking worsens the prognosis of mild abnormalities in cervical cytology.

Guarisi R, Sarian LO, Hammes LS, Longatto-Filho A, Derchain SF, Roteli-Martins C, Naud P, Erzen M, Branca M, Tatti S, Costa S, Syrjänen S, Bragança JF, Syrjänen K.

Acta Obstet Gynecol Scand. 2009;88(5):514-20. doi: 10.1080/00016340902846072.

PMID:
19308752
17.

Management of women with low grade cytology: how reassuring is a normal colposcopy examination?

Cruickshank ME, Cotton SC, Sharp L, Smart L, Walker LG, Little J; TOMBOLA Group.

BJOG. 2015 Feb;122(3):380-6. doi: 10.1111/1471-0528.12932. Epub 2014 Jun 20.

19.

Baseline human papillomavirus status of women with abnormal smears in cervical screening: a 5-year follow-up study in The Netherlands.

Prinsen CF, Fles R, Wijnen-Dubbers CW, de Valk HA, Klaassen CH, Mravunac M, Horrevorts AM, Thunnissen FB.

BJOG. 2007 Aug;114(8):951-7. Epub 2007 Jun 18.

20.

[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].

Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7. Chinese.

PMID:
16635326

Supplemental Content

Support Center